
Advos
Advos.io
@advos
16906 articles
Articles

Fairchild Gold to Acquire Nevada's Golden Arrow Project in $5 Million Deal
Fairchild Gold Corp. (TSX-V: FAIR) has signed a Memorandum of Understanding to acquire a 100% interest in the Golden Arrow Project, an advanced-stage gold property located along Nevada's Walker Lane Shear Zone. The US$5 million transaction represents a valuation of approximately US$12 per ounce of gold in the ground, positi...
October 8, 2025Read more

Three Emerging ASX Tech Stocks Show Breakout Potential in AI, Memory and Medical Sectors
The global technology sector never sleeps, but the next wave of high‑potential Australian tech stocks isn’t coming from the big household names. While investors talk about giants like Xero and WiseTech, three emerging ASX technology companies are quietly demonstrating the kind of breakout behaviour traders dream of.
October 8, 2025Read more

Audius Launches Artist Coin Feature Enabling Musicians to Create Custom Crypto Tokens
Audius, the largest decentralized music discovery and marketplace platform, has announced that verified artists can now create their own Solana-based crypto coins directly on the platform. This development represents a significant shift in how musicians can engage with their fanbase, transforming traditional fan clubs into ...
October 8, 2025Read more

Beeline Holdings CEO Details Digital Mortgage Platform's Accelerated Path to Profitability
Beeline Holdings, a digital mortgage platform trading on NASDAQ under BLNE, is making significant strides in transforming the mortgage industry for millennial and Gen Z homebuyers. CEO and Co-Founder Nick Liuzza recently appeared on The TechMediaWire Podcast to outline the company's progress and strategic direction, reveali...
October 8, 2025Read more

PowerBank Partners with Intellistake Technologies to Test IntelliScope AI Agents for Energy Sector
PowerBank Corporation (NASDAQ: SUUN) has been selected as an enterprise beta partner by Intellistake Technologies Corporation to participate in the continued development of the IntelliScope AI suite. The partnership involves PowerBank providing long-term testing and feedback to help refine IntelliScope's first enterprise-fa...
October 8, 2025Read more

CAYO Nutraceuticals Launches Ten Times More Potent Tanning Gummy with Enhanced Astaxanthin Formula
CAYO Nutraceuticals has unveiled an upgraded version of its popular tanning gummy featuring a formula ten times more potent than its predecessor due to significantly elevated astaxanthin concentration. This enhancement positions the company to offer what it describes as the best tanning gummy available, enabling users to ac...
October 8, 2025Read more

REA Emerges as Leading Provider of Appfolio Bookkeeping Services for Property Management Sector
REA has established itself as a prominent provider in the property management industry through its comprehensive Appfolio bookkeeping services, addressing the critical financial management needs of property owners and managers. The company's focus on precision and reliability in financial oversight represents a significant ...
October 8, 2025Read more

NextPlat Corp Reports Q4 Progress with $2 Million Cost Savings and Healthcare Expansion
NextPlat Corp (NASDAQ: NXPL, NXPLW) has issued a comprehensive shareholder update detailing operational progress and strategic initiatives for the remainder of 2025, with Interim CEO Charles M. Fernandez reporting significant advancements across all business divisions. The company has implemented a comprehensive restructuri...
October 8, 2025Read more

OptimumBank Holdings Reports $3.6M Q2 Earnings, Surpasses $1 Billion in Assets
OptimumBank Holdings Inc. (NYSE American: OPHC) reported second-quarter 2025 earnings of $3.6 million while surpassing the significant milestone of $1 billion in total assets. The Florida-based community bank also revealed that deposits are growing at a double-digit annualized pace, signaling strong financial health and cus...
October 8, 2025Read more

ESGold Corp. Begins On-Site Validation at Colombian Planta Magdalena Project
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) has initiated on-site validation and due diligence activities at its Planta Magdalena Project in Colombia, marking a significant transition from planning to operational execution. The company's geological and engineering team has arrived in Colombia to conduct comprehensive field asse...
October 8, 2025Read more

Izotropic Corp. Advances Breast CT Technology with Personalized Radiation Dosing and $375K Financing
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) is intensifying its commercialization strategy for breast cancer imaging technology through a combination of new financing and breakthrough innovations in personalized radiation dosing. The medical device company recently secured $375,000 through a non-brokered private placement to ...
October 8, 2025Read more

TransCode Therapeutics Acquires Polynoma, Secures $25 Million Investment to Advance Oncology Pipeline
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) has entered into a definitive agreement to acquire Polynoma LLC, a privately held immuno-oncology company developing seviprotimut-L, a late-stage polyvalent shed antigen vaccine for the adjuvant treatment of stage IIB and IIC melanoma. Concurrent with the acquisition, TransCode se...
October 8, 2025Read more

Forward Industries Launches Zero-Commission Solana Validator on DoubleZero Network
Forward Industries has launched an institutional-grade validator node on the Solana blockchain, powered by DoubleZero's high-performance global network for distributed systems. The validator operates at 0% commission, allowing users to stake at no cost while supporting the company's transition from capital provider to activ...
October 8, 2025Read more

Quantum BioPharma Launches $7 Million Whistleblower Program Targeting Stock Manipulation
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) has launched a significant whistleblower reward program that offers cash rewards of up to $7 million for verifiable evidence of stock manipulation involving the company's shares. This initiative represents one of the largest corporate whistleblower programs in the biopharmac...
October 8, 2025Read more

Railtown AI Technologies to Acquire AI Partnerships Corp., Creating Canada's First AI Affiliate Marketplace
Railtown AI Technologies Inc. has entered into an amalgamation agreement to acquire all issued and outstanding shares of AI Partnerships Corp. through a three-cornered amalgamation, making AIP a wholly owned subsidiary of Railtown. The transaction involves the issuance of 40 million shares at a deemed price of $0.50 per sha...
October 8, 2025Read more

Ocumetics Reports Promising Early Results for Accommodating Intraocular Lens
Ocumetics Technology Corp. has reported encouraging one-month safety and vision performance results for the first patients receiving the company's Ocumetics Accommodating Intraocular Lens in clinical trials. The early outcomes demonstrate promising safety profiles and visual performance that could represent a significant ad...
October 8, 2025Read more

Oncotelic's Injectable Everolimus Shows Promise in Boosting Drug Bioavailability for Breast Cancer Treatment
Oncotelic Therapeutics Inc. has received clearance to begin Phase 1 clinical trials for Sapu003, an injectable formulation of Everolimus (marketed as Afinitor) that could revolutionize breast cancer treatment by significantly improving drug bioavailability. The development represents a potential breakthrough in oncology the...
October 8, 2025Read more

Izotropic Corporation Highlights Critical Need for Advanced 3D Breast Imaging Technology
During Breast Cancer Awareness Month, Izotropic Corporation emphasized the critical limitations of current breast cancer imaging technologies and the substantial market opportunity for its developing IzoView Breast CT Imaging System. With more than 2.3 million new breast cancer cases reported globally each year and over 315...
October 8, 2025Read more

Oncotelic Therapeutics Announces Phase 1 Trial Enrollment for Novel Intravenous Everolimus Formulation in Australia
Oncotelic Therapeutics, through its joint venture GMP Biotechnology Ltd. with Dragon Overseas Capital Ltd., has announced that patient enrollment is now open for a Phase 1 clinical trial of Sapu-003, a novel intravenous Deciparticle formulation of everolimus. The trial represents the first clinical investigation of an intra...
October 8, 2025Read more

Ohio State Researchers Identify Key Mechanism Behind Cancer Immunotherapy Failures
A new study from Ohio State University Wexner Medical Center has revealed why cancer immunotherapy fails in 60-80% of patients, identifying a previously unknown stress pathway that cripples immune cells' ability to attack tumors. The research discovered the TexPSR pathway, which floods weakened immune cells with misfolded p...
October 8, 2025Read more

Gold Producers with Strong Cash Flow Positioned as Market Leaders Amid Economic Uncertainty
Gold prices continue to reach unprecedented levels, with spot gold recently trading above $3,800 per ounce as markets anticipate further Federal Reserve rate cuts and continued U.S. dollar weakness. This economic environment, characterized by easing real rates and a global shift toward scarce, nonsovereign assets, has creat...
October 8, 2025Read more